Floretyrosine f-18 - Generic Drug Details
What are the generic drug sources for floretyrosine f-18 and what is the scope of freedom to operate?
Floretyrosine f-18
is the generic ingredient in one branded drug marketed by Telix and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for floretyrosine f-18
Generic Entry Date for floretyrosine f-18*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for floretyrosine f-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Telix | PIXCLARA | floretyrosine f-18 | SOLUTION;INTRAVENOUS | 218592-001 | Sep 11, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
